Missed Chinese GMP deadline brings shutdown risk for vaccine/sterile product makers
This article was originally published in SRA
Executive Summary
As many as 65% of the established companies that make vaccines and other sterile products in China risked being shut down after failing to meet the country's end of 2013 deadline to comply with good manufacturing practice (GMP) rules1.